Andrew J. Warmus focuses his practice on domestic and cross-border mergers and acquisitions, joint ventures, and other strategic transactional matters. He has broad experience representing private equity firms and other financial sponsors, multinational public companies, private companies, and founders in material and transformative transactions across multiple industries, with significant experience in the life sciences sector, including pharmaceuticals, diagnostics, and medical devices.
Referenzmandate
- Represented Solventum Corporation in the acquisition of Acera Surgical Inc.
- Represented VB Spine in the acquisition of Stryker’s core spine business
- Represented Swedish Orphan Biovitrum AB in the acquisition of Arthrosi Therapeutics, Inc
- Represented Select Equity Group L.P. in multiple platform company acquisitions and subsequent add-on transactions
- Advised Alnair Therapeutics, Inc. on various matters, including corporate governance, licensing, and venture finance
- Represented Performant Capital in multiple platform company acquisitions and add-on transactions
Auszeichnungen
- Legal 500 USA, Recommended Lawyer, 2022
Praxisgruppen und Fokusthemen
Internationale Märkte
Qualifikation
Education
- University of Chicago, MBA
- Marquette University Law School, JD
- Colorado State University, BS
Admissions
- Illinois
- Wisconsin